# Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis

> **NCT07186465** · PHASE4 · RECRUITING · sponsor: **Mahidol University** · enrollment: 100 (estimated)

## Conditions studied

- Cystitis, Recurrent
- Urinary Tract Infections

## Interventions

- **DRUG:** Nitrofurantoin
- **DRUG:** Gynoflor

## Key facts

- **NCT ID:** NCT07186465
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-11
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07186465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07186465, "Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07186465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*